Literature DB >> 21151034

Innate immune mechanisms of colitis and colitis-associated colorectal cancer.

Maya Saleh1, Giorgio Trinchieri.   

Abstract

The innate immune system provides first-line defences in response to invading microorganisms and endogenous danger signals by triggering robust inflammatory and antimicrobial responses. However, innate immune sensing of commensal microorganisms in the intestinal tract does not lead to chronic intestinal inflammation in healthy individuals, reflecting the intricacy of the regulatory mechanisms that tame the inflammatory response in the gut. Recent findings suggest that innate immune responses to commensal microorganisms, although once considered to be harmful, are necessary for intestinal homeostasis and immune tolerance. This Review discusses recent findings that identify a crucial role for innate immune effector molecules in protection against colitis and colitis-associated colorectal cancer and the therapeutic implications that ensue.

Entities:  

Mesh:

Year:  2010        PMID: 21151034     DOI: 10.1038/nri2891

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  128 in total

1.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

Review 3.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

4.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

5.  Factors influencing the composition of the intestinal microbiota in early infancy.

Authors:  John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

6.  Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

Authors:  Kyoko Katakura; Jongdae Lee; Daniel Rachmilewitz; Gloria Li; Lars Eckmann; Eyal Raz
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

7.  Loss of single immunoglobulin interlukin-1 receptor-related molecule leads to enhanced colonic polyposis in Apc(min) mice.

Authors:  Hui Xiao; Weiguo Yin; Mohammed A Khan; Muhammet F Gulen; Hang Zhou; Ho Pan Sham; Kevan Jacobson; Bruce A Vallance; Xiaoxia Li
Journal:  Gastroenterology       Date:  2010-04-21       Impact factor: 22.682

Review 8.  Optimizing the safety of biologic therapy for IBD.

Authors:  Shanika de Silva; Shane Devlin; Remo Panaccione
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-02       Impact factor: 46.802

9.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

10.  Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms.

Authors:  Maya Saleh; John P Vaillancourt; Rona K Graham; Matthew Huyck; Srinivasa M Srinivasula; Emad S Alnemri; Martin H Steinberg; Vikki Nolan; Clinton T Baldwin; Richard S Hotchkiss; Timothy G Buchman; Barbara A Zehnbauer; Michael R Hayden; Lindsay A Farrer; Sophie Roy; Donald W Nicholson
Journal:  Nature       Date:  2004-05-06       Impact factor: 49.962

View more
  167 in total

Review 1.  Inflammasomes in health and disease.

Authors:  Till Strowig; Jorge Henao-Mejia; Eran Elinav; Richard Flavell
Journal:  Nature       Date:  2012-01-18       Impact factor: 49.962

Review 2.  Effector functions of NLRs in the intestine: innate sensing, cell death, and disease.

Authors:  Garabet Yeretssian
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage.

Authors:  Donna Kirkland; Alicia Benson; Julie Mirpuri; Reed Pifer; Baidong Hou; Anthony L DeFranco; Felix Yarovinsky
Journal:  Immunity       Date:  2012-02-01       Impact factor: 31.745

Review 4.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

5.  Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis.

Authors:  Roni Nowarski; Ruaidhrí Jackson; Nicola Gagliani; Marcel R de Zoete; Noah W Palm; Will Bailis; Jun Siong Low; Christian C D Harman; Morven Graham; Eran Elinav; Richard A Flavell
Journal:  Cell       Date:  2015-12-03       Impact factor: 41.582

6.  The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse.

Authors:  Carol J Díaz-Díaz; Sean M Ronnekleiv-Kelly; Manabu Nukaya; Peter G Geiger; Silvia Balbo; Romel Dator; Bryant W Megna; Patrick R Carney; Christopher A Bradfield; Gregory D Kennedy
Journal:  Ann Surg       Date:  2016-09       Impact factor: 12.969

Review 7.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

Review 8.  Inflammasomes in intestinal inflammation and cancer.

Authors:  Grace Y Chen; Gabriel Núñez
Journal:  Gastroenterology       Date:  2011-10-15       Impact factor: 22.682

9.  Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell Differentiation.

Authors:  Ka Lung Cheung; Fan Zhang; Anbalagan Jaganathan; Rajal Sharma; Qiang Zhang; Tsuyoshi Konuma; Tong Shen; June-Yong Lee; Chunyan Ren; Chih-Hung Chen; Geming Lu; Matthew R Olson; Weijia Zhang; Mark H Kaplan; Dan R Littman; Martin J Walsh; Huabao Xiong; Lei Zeng; Ming-Ming Zhou
Journal:  Mol Cell       Date:  2017-03-03       Impact factor: 17.970

Review 10.  Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.

Authors:  Masayuki Nagahashi; Nitai C Hait; Michael Maceyka; Dorit Avni; Kazuaki Takabe; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Biol Regul       Date:  2013-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.